FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
Posted: 29 October 2024 Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara®[1]), an agent for the imaging of glioma. The application has been…
4DMedical Secures $1.9M Grant to Ramp-up Trials for ‘Safer, Cheaper’ Lung Imaging
Posted: 29 October 2024 4DMedical has been awarded $1.9 million from the Federal Government under the latter’s CRC-P (Cooperative Research Centres Projects) grant program to fund its expansion and ramp-up of clinical trials for CT:VQ, being run in…
Investigations into lung cancer and into epigenetics recognised with 2 x $1.25 million CSL Centenary Fellowships
Posted: 29 October 2024 Two Australian scientists have each been awarded CSL Centenary Fellowships, valued at $1.25 million over five years. The Fellowships were presented at the Australian Academy of Health and Medical Sciences Annual Meeting on Thursday…
Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial
Posted: 21 October 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces that the first part (Part A, single dose) of the…
MTPConnect Cements US Medtech Links Through MoU with Influential Medical Alley
Posted: 21 October 2024 MTPConnect, Australia’s life science innovation accelerator, and Medical Alley, headquartered in Minnesota have committed to ongoing collaboration to support the growth of medtech companies with the signing today of a Memorandum of Understanding. The…
$22 million investment in cancer clinical trials to save lives throughout Australia
Posted: 21 October 2024 The Minister for Health and Aged Care, the Hon Mark Butler MP, today announced the successful applicants for the 2024-2027 Support for Cancer Clinical Trials (Clinical Trials) program, with a total of $22.19 million…
Recruitment Restarts in Accent Pancreatic Cancer Trial
Posted: 21 October 2024 Amplia has announced that recruitment of the final cohort of patients in the ACCENT clinical trial has begun with the first patient having started on trial this week. A total of 50 patients are…
South African and Australian health product regulators to share regulatory information and expertise
Posted: 14 October 2024 The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. The MoU…
2024 Prime Minister’s Prize for Innovation
Posted: 9 October 2024 Cytopia’s Professor Andrew F Wilks and Dr Chris Burns received the 2024 Prime Minister’s Prize for Innovation. The prize recognises their outstanding contribution to drug discovery and development in Australia. Prof Wilks and Dr Burns…
Immutep Completes Patient Enrolment in Randomised Phase II of AIPAC-003 Trial in Metastatic Breast Cancer
Posted: 8 October 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces patient enrolment has been completed in the randomised Phase…
New drug could be answer to an overlooked yet devastating type of dementia
Posted: 8 October 2024 Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and countless others as young as 35: behavioural variant frontotemporal…
World first: Australian scientists uncover “plant-like” behaviour in important human cell regulator, opening up a new drug target for cancer, other diseases
Posted: 8 October 2024 A team of scientists from Monash University has solved the structure of a protein known as ‘LYCHOS’, which can detect and regulate cell growth by sensing cholesterol levels in the body. Human cells need…
